se of nalbuphine, dexmedetomidine and tramadol for treatment of post-spinal shivering after Caesarean section.
Not Applicable
- Conditions
- Health Condition 1: O754- Other complications of obstetric surgery and procedures
- Registration Number
- CTRI/2021/07/034963
- Lead Sponsor
- Government Institute of Medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1. Patients from obstetrics group aged between 20â??40 years of ASA grade I and II undergoing caesarean section.2. Patients who will give a valid informed written consent.
3.Patients who will develop shivering of grade 3or4.
Exclusion Criteria
1. Patients of age group between 20-40belonging to ASA grade III and IV.
2. Patients with known hypersensitivity to tramadol, dexmedetomidine and nalbuphine.
3. Patients who will not give valid informed consent.
4. Patients who will have shivering before spinal anaesthesia.
5. Patients who will have shivering before delivery.
6. Contraindication of spinal anaesthesia.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To clinically compare the efficacy of either of three drugs to effectively abolish post spinal shivering.Timepoint: 0,5, 10, 15, 30 min, 60 min
- Secondary Outcome Measures
Name Time Method To assess <br/ ><br>â?¢Hemodynamic effects <br/ ><br>â?¢Sedation <br/ ><br>â?¢Side effectsTimepoint: <br/ ><br>0,5, 10, 15, 30 min, 60 min